PET/CT在肝细胞肝癌中的应用现状  

The application status of PET/CT in hepatocellular carcinoma

作　　者：王涛[1] 王春梅[1] 李剑波[1] 王雪梅[1] Wang Tao;Wang Chunmei;Li Jianbo;Wang Xuemei(Department of Nuclear Medicine,the Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China)

机构地区：[1]内蒙古医科大学附属医院核医学科,呼和浩特010050

出　　处：《国际放射医学核医学杂志》2021年第5期319-324,共6页International Journal of Radiation Medicine and Nuclear Medicine

摘　　要：肝细胞肝癌(HCC)是全球癌症患者病死的主要原因之一。各种影像学技术为HCC的临床诊疗提供了重要信息。随着PET/CT在肿瘤学领域研究的不断进展,其在HCC的诊断、鉴别、精准分期以及局部残留和复发的评估方面起着至关重要的作用。双示踪技术已经成为辅助HCC诊断的重要技术,新型示踪剂的出现提高了PET/CT对HCC的诊断能力。笔者就目前PET/CT在HCC中的应用现状进行综述。Hepatocellular carcinoma(HCC)is one of the leading causes of cancer mortality worldwide.Various imaging modalities provide important information about HCC for its clinical management.With the continuous progress of PET/CT research in oncology,it has played crucial roles in detecting,distinguishing,accurately staging,and evaluating local,residual and recurrent HCC.Dual tracer technology has become an important technology to assist HCC diagnosis,and the advent of new radiotracers has improved the ability to detect lesions.This paper reviews the current status of PET/CT for HCC.

关 键 词：正电子发射断层显像术 体层摄影术 X线计算机 癌 肝细胞 放射性示踪剂 

分 类 号：R730.44[医药卫生—肿瘤] R735.7[医药卫生—临床医学]